HER3: Survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer
A new research perspective was published in Oncotarget Volume 14 on May 10, 2023, entitled, “HER3- A key…
Browsing: Pancreatic ductal adenocarcinoma (PDAC)
Expansion of cell-to-cell communication drives the early development of pancreatic cancer, new research in mice finds
Discussions of cancer often stress the genetic mutations that drive disease by altering the normal…
This killer protein causes pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. It’s also one…
Highlighting the molecular mechanism underlying pancreatic cancer development
Researchers visualized the protein binding site of the (pro)renin receptor known to be involved in…
New genetic culprit suspected in the onset of pancreatic cancer
New research out of VCU Massey Cancer Center, USA, points to the inactivation of a…
Survival is a mixed matter for deadliest of pancreatic cancers
Pancreatic ductal adenocarcinoma (PDAC) is the most common and most lethal form of pancreatic cancer.…
Scientists discover mechanism controlling spread of pancreatic cancer
Scientists have shown it is possible to reverse a key process that allows pancreatic cancer…
Exercise amplifies immune attack on pancreatic cancer
Aerobic exercise reprograms the immune system to reduce pancreatic tumour growth and amplify the effects…
Pancreatic cancer: overcoming resistance to immunotherapies
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. The disease is…
Finding the weak points in radiation-resistant pancreatic cancer cells
Of all the different types of cancer known, a subtype of pancreatic cancer called pancreatic…